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Summary
A method is described by which the time-course of thrombin
generation in plasma can be obtained from a continuous optical
density recording of p-nitroaniline (pNA) production in a 2:3
diluted plasma. A chromogenic substrate, methylmalonyl-me-
thylanalyl-arginyl-pNA (SO 68), is used that is specifically split by
thrombin but at a low rate. The thrombin that appears and
disappears in the plasma does not split more than 5% of the
substrate added, so the rate of substrate conversion is in good
approximation proportional to the amidolytic activity in the
plasma over the entire period of thrombin generation. The course
of the enzyme concentration can be calculated from the amido-
lytic activity curve. It is shown that the thrombin generation
curves obtained in this way are essentially identical to those
obtained via the classical subsampling method.
The presence of SQ 68 influences the amount of free thrombin
that appears in plasma because it competitively inhibits the
inactivation of thrombin by AT III and o,2 macroglobulin. The
inhibition of the thrombin peak by heparin, relative to an
uninhibited control, remains unaltered by the presence of the
substrate.
From the course of thrombin activity and the prevailing decay
constants, the course of prothrombin conversion velocity can be
calculated. Prothrombin conversion was seen to be inhibited at
high (>500 pM) substrate concentrations only, and experimental
conditions are found under which the inhibition of the clotting
process by the substrate is negligible.
The amidolytic activity is the sum of the activities of free
thrombin and of the o2 macroglobulin-thrombin complex formed
Via a mathematical procedure the amount of SQ 68 that has been
split by thrombin alone and not by the o,2 macroglobulin-thrombin
complex, can be derived from the course of the optical density.
The total amount of SQ 68 eventually split by thrombin alone is
proportional to the surface under the thrombin generation curve,
i. e. to the time-integral of free thrombin. This value, that we call
the thrombin potential (TP), directly indicates how much of any
physiological substrate can potentially be split by the thrombin
being generated in the plasma
Introduction
The thrombin generation curve (TGC), i. e. the course of
appearance and disappearance of thrombin in triggered plasma,
gives information on the process of blood coagulation that is
difficult to obtain otherwise. lts determination requires repeated
Correspondence to: Dr. H C Hemker, Departmcnt of Biochemistry,
Univ of Limburg, Postbus 676, 6200 MD Maastricht, The Netherlands
subsampling from the activated plasma sample which, even when
automated as far as possible, requires intensive experimentation
and is not suited for routine use (1-3).
Optical registration of a signal from thrombin-related amido-
lytic activity in defibrinated plasma is in principle possible by
recording product formation from a chromogenic thrombin-
substrate added to the plasma. Current substrates are unsuitable,
however, because they will be exhausted long before thrombin
generation is over, even when added at the highest concentration
that is practically possible. A slow reacting thrombin substrate
will therefore have to be used, i. e. the turnover (ft.",) of this
substrate by thrombin has to be low.
It is inherent to the presence of a chromogenic substrate that
the physiological reactions of thrombin are interfered with. The
substrate will act as a competitive inhibitor of reactions in which
thrombin partakes. In order to minimize inhibition, the substrate
should be present at a concentration that is far from saturating the
enzyme. By definition the enzyme is half saturated if the substrate
concentration equals the Michaelis constant (K",). The concentra-
tion in the experiment therefore should be below K-. On the
other hand the total amount of substrate converted should remain
small as compared to the initial amount present, so that the
inhibitory effects remain constant during the experiment. This
means that relatively high substrate concentrations are required
that however remain below K-, hence K- should be high.
In this article we show that methylmalonyl-methylalanyl-
arginyl-p-nitroaniline (SO 68) is a substrate with kinetic proper-
ties that allow continuous registration of thrombin activity. The
turnover is low, but high enough to generate a well measurable
signal, even though only a small fraction of the initial amount of
substrate is consumed during the experiment. The inhibitory
effect on prothrombin conversion remains small.
In clotting plasma, conversion of a chromogenic thrombin-
substrate is caused by two different molecular species: free
thrombin and the thrombin-o2 macroglobulin complex (or M-
thrombin) (1, 2). We will show that the optical density tracing of
p-nitroanilide production can be dissected mathematically in two
parts, the one due to the action offree thrombin and the other to
that of 02 macroglobulin-thrombin. The thrombin-dependent
curve shows a steady end-level, which represents the total amount
of chromogenic substrate that has been converted by free
thrombin during the experiment. This amount is proportional to
the amount of any other (physiological) substrate that thrombin
generated in that sample can potentially split. It is a direct
indicator of the amount of enzymatic "work" that thrombin can
carry out during its lifetime in the activated plasma sample.
Thrombin acts on a great variety of physiological substrates, to
the general effect of making it the pivotal enzyme in haemostasis
and thrombosis. The amount of enzymatic thrombin-action that
can potentially be triggered in a given plasma is therefore likely to
be a parameter to indicate the thrombin-mediated anti-bleeding
and/or prothrombotic capacity of that plasma. We call this value
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the experiment and uninterpretable optical signals are the result The
fibrin formed was discarded by centrifugation (10 min, 5,000 x g' 4" C) or
by winding it on a small plastic spatula. The concentrations of factors II,
VII, VIII, IX, X, XI and XII did not significantly change by the reptilase
treatment (1).
ln order to obtain a plasma in which the kinetic constants of SQ 68
could be determined directly, heated defibrinated plasma was prepared by
leaving defibrinated plasma at 60' C for 60 min Any precipitate that
formed was removed by centrifugation for 10 min at 10,000 x 8. It was
checked that thrombin- or factor Xa added to this preparation did not
loose activity in the course of 30 min
Heparin contalning plasma samples were obtained from volunteers
that received subcutaneously either 5,000 units of unfiactionated heparin
or 40 mg of Enoxaparin or 1 mg/kg body weight of Enoxaparin. This was
done in the course of a study carried out by Dr A.-V Bendetowicz in our
laboratory, that will be rcported on separately. In this article the samples
are used only to compare different ways of assessing the effect of heparin
on the thrombin potential
Thrombin
The euglobulin fraction fiom dcfibrinated plasma was obtained by acid
precipitation at low ionic strength as described by Josso and Prou-
Wartelle (a). The precipitate was dissolved in half the original volume of
buffer A, containing 0.02 M trisodium citrate, so as to obtain a concentra-
tion of clotting factors that was not lower than that in the original plasma
No inhibitor activity could be detectcd in this solution Thrombin was
generated in this preparation at 37" C by addition of a trace of
recombinant tissue factor and CaCl2 to a final concentration of 16 7 mM.
The thrombin solution obtained was either used as such, or o-thrombin
was prepared according to Pietcher et al. (5).
Factor Xa
Factor Xa was prepared according to Mertens and Bertina (6)
Manual Determination of Thrombin Generation in Plasma
To 240 pl of defibrinated plasma is added 60 pl of buffer A containing
SQ68 at the desired concentration Thrombin formation is started by the
addition of 60 pl of a solution containing 100 mM of CaCl2 and recom-
binant tissue factor.
At regular intervals 10 pl samples are withdrawn and subsampled into
490 pl of buffer B containing 200 pM 52238. After about 2 min the
reaction is stopped with 300 pl of 1 M citric acid The moment of sampling
and stopping dircctly are recorded on a personal computer with pushbut-
ton-equipped pipettes The cuvettes are read at 405 nm in a double
wavelcngth (405-546 nm) dedicated instrument prepared in our work-
shop, using a personal computer for data recording. For full details on the
method sce ref 1.
Decay Constants of Thrombin in Plasma
To 120 pl of defibrinated plasma and 40 pl of buffer A, at 37' C, 10 pl
of a thrombin preparation were added so as to obtain a final concentration
of 100 nM. At suitable intervals (5-10 s) 10 pl samples were drawn and
tested for thrombin as described above
Thc amidolytic activities (C,) were fitted to the three parameter curve
Ct: C* + (Co - C-) . e k r, where k is the decay constant (ft6..), C6 is the
initial amidolytic activity and C- is the residual, steady end-level activity
due to the o2 M-thrombin complex In our hands, the standard error of a
single estimation is below 7To aslong as half life times exceed 4 s (k,1"" :
10 min-l) At shorter half life times it increases proportionally with t6"",
with about 1olo per min I
The decay constant that is obtained in this way is the sum of the decay
constants of the reaction of thrombin with the different inhibitors of
plasma We distinguish k2,the u2 macroglobulin-dependent constant and
/.1, that governs the non-o,2 macroglobulin-dependent reactions, princi-
pally (-85%) AT III. We calculated k2 fiom the relation k2 f : (C-lcd
k6"" (where f : 0.763, i e. the ratio of the amidolytic activity of
aequimolar amounts of o2 M-thrombin and thrombin, or the ratio of their
ft.u, values; see refs. I and 2 and Thble 1). Alternatively k2 ' f can be
estimated directly from the optical density traces as described in the
annexe
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Fig. 1 A simulation of continuous thrombin measurements with difTerent
substrates A given experimental amidolytic activity curve (I) is thought
to occur in a reaction medium that contains a chromogenic substrate.
Then the course of the enzyme concbntration is calculated from the course
of the velocity of substrate conversion for substrates at different concen-
trations and with different kinetic parametcrs (drawn lines)
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the thrombin potential (TP). With the aid of the method described
here the TP can be easilv determined.
Materials and Methods
Materials
Methylmalonyl-methylalanyl-arginyl-pNA (SO 68) was synthesized by
Serbio Laboratories, France (European Patent 88400304.7).
The chromogenic substrate used for thrombin estimation in subsamples
was H D-Phe-Pip-Arg-PNA (52238) from KABI, Sweden
Reptilase was obtained from Laboratoires Stago (Asnidres, France), a
solution was made according to the instructions of the manufacturer.
As a trigger for coagulation we used relipidated recombinant tissue
factor (a kind gift of Dr Yale Nemerson, Mount Sinai, New York City,
USA), suppticd with 1 5 pM phospholipid (20% phosphatidylserine, 80%
phosphatidylcholine) diluted so as to give a peak of -250 nM thrombin in
normal plasma
Buffer A contains 0.05 M Tiis-HCl at pH 7 35, 0.1 M NaCl, 0.5%"
bovine serum albumin. Buffer B is identical but at pH 7 9 and contains in
addition 20 mM EDTA
Plasma
Blood from healthy donors was collected on 0 13 M trisodium citrate;
nine parts of blood to one part of citrate solution A first ccntrifugation
was performed at 900 x g, at 15" C for 15 min A second centrifugation
was done for 15 min at 15'C and 10,000 x g. PPP was pooled from at
least 10 donors and a third centrifugation was carried out at 4' C, fot t h
at 23,000 x g, this plasma was stored at -80" C. It was checked that the
clotting factors and the antiproteases were in the normal range.
All thrombin generation experimcnts were carried out in defibrinated
plasma, that was obtained by mixing an aliquot of plasma with 1:50
volume of a reptilase solution, letting a clot form for 10 min at 37' C and
keeping the clotted plasma at 0'C for 10 min It is good to occasionally
check that the reptilase-induced clotting time of normal plasma is around
300 s. If it is substantially longer than the reptilasc solution has lost
activity and incomplete defibrination may result. Clot formation during
618
Table I Kinetic constants of SQ68
Enzyme Conditions K,,
(pM)
Thrombin
Thrombin
o2 M-thrombin
Factor Xa
Factor Xa
Heatcd plasma 819 + 19 0.38 + 0.002 60
Buffer A 830 + 48 0.46 + 0.04 8
Serum 788 + 11 0.29 + 0.006 60
Heatcd plasma 3,210 + 793 | 9 + 0.12 8
Buffer A 3.930 + 105 2.9 + 0.16 16
Experimental
Kinetic Properties of the Chromogenic Substrate
We determined the kinetic constants of a number of different
substrates under conditions as close as possible to those under
which we wanted to use them, i. e. in2:3 diluted plasma. In order
not to be hindered by thrombin inactivation the antithrombin
activity was abolished by heating for 60 min at 60' C. We selected
SQ 68 as the one which was converted by thrombin sufficiently
slow, and yet was sufficiently specific for thrombin Table 1 gives
the kinetic constants of this substrate.
In order to get an impression of what substrate concentrations
should be used, we mathematically simulated substrate conver-
sion in a plasma in which thrombin is generated. As input we used
the three variables: initial substrate concentration, Michaelis
constant (K-) and catalytic constant (k"",) of the splitting of the
substrate by thrombin and a typical thrombin generation curve in
normal plasma after triggering with thromboplastin (mean of 5
curves). The program calculated the velocity of substrate conver-
sion according to the classical formula rt : k"ut. Er . Sr/(K- + Sr).
(The subscripts r indicate the variable at time t, so E, is the amount
of thrombin as given by the thrombin generation curve, S, is the
amount of substrate remaining at time l.) Then the apparent E,'
was calculated as in an actual experiments, i. e. by calculating Er'
: v, . (K- + .S6)/k"ut . Se. In this formula Ss replaces S,, so that E,'
is an approximation of the real E,.
From the results obtained it can be seen (Fig.1, curve C) that
at SQ 68 concentrations of 25 pM the course of E, so calculated
already fits closely to the actual thrombin generation curve. A
conventional substrate would only render the first part of the
TGC, even when added at impracticably high concentrations
(curves A and B).
The presence of a thrombin substrate in plasma, slows down
the action of antithrombins because they act on free thrombin
only and not on the thrombin-chromogenic substrate complex.
This makes that in actual practice the results with conventional
substrates would be even worse than suggested by the simulation
experiments. Even if we double the thrombin values of the
normaf atwe,25 pM of SQ68 would st i l l  give a l ine hardly
distinguishable from the actually measured points (results not
shown).
From these simulation experiments it is clear that a substrate
with the kinetic properties of SQ 68 will theoretically indicate
correctly the amount of free thrombin present when it is added at
concentrations of 25 pM and higher. In order to obtain a
sufficiently high signal considerably higher concentrations are
used in practice (see below).
The kinetic constants of SQ68 with thrombin, o,2 M-thrombin
and factor Xa as a substrate are shown in Thble 1.
Continuous Registration of the Thrombin Generation Curve
In a disposable plastic semi-microcuvette we added 400 pl of
defibrinated plasma, 100 pl of buffer A, to which substances to be
tested (heparin e. g.) can be added and 60 pl of a solution of
SQ68 so as to obtain the required final substrate concentration
(200-1,000 pM). The reaction was started at zero time by adding
40 pl of recombinant tissue factor in 0.25 M CaCl2. The reagents
were prewarmed to 37'C and the cuvette was thermostated at
that temperature during the measurement.
The optical density at 405 nm was recorded at the pace of 2
measurements per second (Fig.2). We calculated the average of
the first derivative of the OD trace at every 24 measuring points,
i. e. over 12 s intervals (Fig 3, upper frame). From the substrate
conversion velocities so obtained we calculated the enzyme
conditions via the classical formula dS/dr : k.ur. E . S/(K,, + S)
(Fig.3, lower frame).
We also determined manually the course of thrombin activity
in identical reaction mixtures, including different concentrations
of SQ68, by subsampling at 12 s intervals in cuvettes with the
usual thrombin substrate 52238 (Fig.4). Different concentrations
of SQ68 were included in order to register its effect on the
coagulation system. From parallel blank experiments it was seen
that the SQ 68 in the reaction mixture did not add more than
2 mOD (equivalent to about 0.1 nM thrombin) to the signal in the
subsamples, so that the signal obtained could be interpreted in
terms of splitting of 52238. Comparison of the manual data and
those obtained from the continuous registration showed accept-
able resemblance (Fig. 4).
Time (min)
Fig 2 Continuous registration of OD development due to SQ 68 splitting
in plasma triggered with tissue factor Concentrations of SQ68, ftom top
tobot tom: 2 mM, 1 5 mM, 1 mM, 0.5 mM, 02 mM, 0 1 mM. Thelower
tiame represents the first 2 min of the upper frame
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Fig 3 Continuous registration of reaction velocities of SQ68 conversion
and of enzyme concentrations derived from optical density traces. Upper
frame : Reaction velocities of SQ68 conversion calculated as the first
derivatives of the OD traces in Fig 2. From top to bottom: 2 mM,
1 5 mM, 1 mM, 0 5 mM, 0.2 mM (centreJine), 0.1 mM (dotted line).
Lower frame: Enzyme concentrations calculated from the reaction
velocities of SQ68 conversion shown in thc uppcr frame via Et: rt
(K,,, + So)/k n, . 56.
Time (min)
Time (min)
Fig.4 Comparison of thrombin generation curves obtained by subsam-
pling and obtained by continuous registration of SQ68 conversion. At a
sampling interval of 12 s thrombin concentrations were determincd in
defibrinated plasma triggered with recombinant tissue thromboplastin in
the prcscnce of SQ68 (points) and compared to the results from
continuously reading experiments (lines) Upper frame: I control; ! and
- 0.5 mM SQ68; , '  and -  1.5 mM SQ68; lower f rame:
I  a n d . . . . . . . . 0 2 m M  S e 6 8 ; , :  a n d  _  1 . 0 m M  S e 6 8 ;  !  a n d
- 2.0 mM SQ 68
Influence of SQ68 on Thrombin Inactivation
From Figs.3 and 4 it is seen that both in the continuous and in
the manual experiments the presence of SQ68 causes an increase
of the €imount of thrombin measured. This is to be expected
because the substrate competes for the active centre of thrombin
with the natural thrombin inhibitors, such as antithrombin III.
Whether o,2 macroglobulin-mediated thrombin inactivation also is
influenced is open, because this inhibitor leaves the active centre
of thrombin free, at least in the final complex. We determined the
AI III and 02 M-dependent decay constants of thrombin in the
presence of different concentrations of SQ 68 (Table 2). lt is seen
that both constants are decreased by SQ 68 and that l/fd..
increases linearly with the SQ68 concentration (Fig.5).
Influence of SQ68 on Prothrombinase
With the decay constants of Thble 2 we can calculate the
course of the velocity of prothrombin conversion, i. e. the course
620
Concentration SO OB (yM)
Flg 5 The influence of SQ 68 on the decay constants of thrombin in
plasma. I Ovcrall decay of thrombin; + o.2 macroglobulin-dependent
decay; + non-tr2 mocroglobulin-dependent decay
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Fig 6 The influence of SQ68 on prothrombin convelsion in extrinsically
triggered plasma Thc prothrombinasc activities wcrc calculated from the
curves in Fig.3 according to the mcthod of  Rcf .1,  using thc decay
constants of Thble 2 From top to bottom: Control (f); 0.2 mM SQ68
(dot tect) ;  0.5 mM SQ68 (drawn);  1 mM (dot ted A);  I  5 mM (doued B)
and 2 mM (dotted C)
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Frg 8 Correlation between thc thrombin potential and thc lcvel of the o2
macroglobulin-thlombin complcx in serum Samples were obtained from
hcalthy volunteers that had rcccivcd by subcutaneous injection either
5,000 U of unfractionated heparin or 40 or 75 mg of a LMWH prepara-
tion I: Unfractionatcd hcparin; n: low molecular weight heparin
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Fig 7 Comparison of hcparin-induccd inhibition of the thrombin poten-
tial as measured via thc subsampling and via thc continuous method.
Different concentrations (0 01-0.1 U/ml) of unfractionated heparin were
added to normal plasma. The inhibition of the thrombin potcntial
obtained was measured by both methods
of prothrombinase activity from the curves of Fig.4. The results
are shown in Fig. 6. It is evident that significant inhibition of
prothrombinase activity only appears at the higher (>1,000 pM)
concentrations of SQ 68.
Comparison of Inhibitions Found with the
Old and the New Method
In order to compare the continuous and the subsampling
method as to their susceptibility to inhibition, we detcrmined the
inhibition of the area under the TGC, i. e. the thrombin potential,
brought about by different amounts (0.01-0.1 U/ml) of unfrac-
tionated heparin both with the subsampling method and with the
continuous method (Fig.7). A good correlation is found between
the two methods.
The a2 Macroglobulin-thrombin Complex as an Indicator of the Tp
It did not escape our attention that plasma contains a natural
pseudo-substrate of thrombin that is not exhausted during the
B
Time (min)
Fqq 9 Mathematical dissection of the optical density trace from p-
nitroaniline production from SQ68 in clotting plasma. A: Original OD
tracing; B: contribution of the o2 macroglobulin-thrombin complex; C:
contribution of free thlombin; TP: amount of substratc cventually
converted by free thrombin, i. e steady level of C
clotting process, i. e. o,2 macroglobulin. This inhibitor reacts with
thrombin to form the or macroglobulin-thrombin complex. The
complex conserves the amidolytic activity of thrombin against
small substrates and by this activity can be easily assessed. The
amount of the complex eventually formed, is dependent upon the
initial concentration of u,2 macroglobulin, and to the thrombin
potential. Because the concentration of o2 macroglobulin in a
given sample is subject to variation, measuring of the product,
i. e. the a2 macroglobulin-thrombin complex after coagulation is
not a substitute for me asuring the TP with chromogenic substrate,
yet an impression of the TP value can be obtained in this way.
Fig.8 shows that there is a good correlation between the TP
calculated and the residual, o,2 macroglobulin-thrombin depend-
ent, amidolytic activity after coagulation (l : 0.95).
Discussion
The chromogenic substrate, methylmalonyl-methylalanyl-argi-
nyl-pNA (SO 68) has kinetic propertics that allow the entire
course of thrombin-related amidolytic activity in triggered plasma
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Thble 2 Inflrcnce of SQ68 on decay constants, end-levcls of amidolytic
activitv and inhibition of orothrombinase
It has been proposed to calculate the decay constant of
thrombin directly from the optical density trace obtained in a
mixture of AT III, thrombin and Tos-Gly-Pro-Arg-pNA (9). This
is possible only if the concentration of the decay-inhibiting
chromogenic substrate remains constant during the course of
thrombin decay. ln the experiments of ref. 9 up to 34"/o of the
substrate is consumed, so that the inhibition of thrombin decay
constant will vary considerably and continuously during the
experiment. This considerably complicates the evaluation of the
curves. Preliminary experiments show that this complication is
not encountered with SQ 68.
It is not immediately clear whether the o2 macroglobulin
dependent decay constant (k2) should be influenced by the
presence of the chromogenic substrate, because the mechanism of
action of this inhibitor is not that of a pseudo substrate (10). In
Fig. 5 we see that the inverse of the decay constants varies linearly
with the concentration of substrate, i. e that the inhibition is
competitive. This may be caused by the fact that, even though in
the final enzyme-inhibitor complex the active centre of thrombin
is free, the first step in inhibition by o,2 macroglobulin is
proteolytic cleavage of the "bait" region of the inhibitor (10).
From the amidolytic activity curves we calculated the velocity
of prothrombin conversion according to refs. 1. and 2, using k1 and
k2 as obtained in the presence of SQ68 (Fig.6). Prothrombin
conversion is significantly inhibited only at SQ68 concentrations
of 1,000 pM and higher. With low SQ68 concentrations the
experimental noise tends to be important (dotted lines in Fig.3).
We choose 500 pM as a compromise. We think that in SQ68 we
have obtained a reasonably good substrate for continuous regis-
tration of the amidolytic activity. The ideal would be an entirely
specific thromtiin-substrate with a still higher K,,, so that few
thrombin would be occupied in enzyme-substrate complexes and
the substrate would interfere minimally with other thrombin
substrates.
The nearly constant amount of SQ68 present in the experi-
ments acts as a competitive inhibitor on all other reactions in
which thrombin is involved. This does not seem to alter imoor-
tantly the relations within the clotting mechanism. At least the
inhibition brought about by heparins is not significantly influ-
enced by the presence of SQ68 (Fig.7).
Calculation of the Thrombin Generatictn Curve
and the Thrombin Potential (TP)
Fig. 1 shows the general form of a thrombin generation curve
as it is known from previous work. The amidolytic activity
measured is caused by the simultaneous activity of thrombin and
the o2 macroglobulin-thrombin complex. The latter builds up
during the test with a velocity proportional to the amount of free
thrombin available (1). It is responsible for the thrombinlike
amidolytic activity found in serum, i. e. for the non-zero end-level
of the TGC. In TGCs that are determined with fibrin as the
substrate for the thrombin in the subsamples, this phenomenon is
not seen because n2 M-thrombin does not act on fibrin (11). A
simple mathematical treatment of the data allows to obtain the
course of free thrombin from the amidolytic activity curve if we
know k2 . f, i.e.the pseudo-first order constant of the interaction
between o,2 macroglobulin and thrombin (fr2) multiplied by I the
ratio of the ft"o1 of a,2 macroglobulin-thrombin over the k"u, of
thrombin (1, 2). The introduction of the constant / in the
calculations accounts for the difference between k"u, of free
thrombin and u2 macroglobulin-thrombin. The differences
between K- are not accounted for but the error that is thus
introduced remains below 2.57". A calculation analogous to that
giving the thrombin curve from the amidolytic activity curve can
be carried out on the experimental OD trace (Fig 9A). This
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Inhib - Inhibition of prothrombin conversion.
Cons - Percentage of the initial SQ 68 concentration consumed in 10 min
to be followed in a spectrophotometer The reaction velocity of
substrate conversion can be obtained in real time from the first
derivative of the OD-tracing. It is in good approximation propor-
tional to the amidolytic enzyme activity because maximally 8% of
the substrate is consumed during the first 10 min of the reaction
The proportionality factor is obtained from classical enzyme
kinetics: E : v (K^ + S)//."ut . Ss. Fig.4 shows that indeed in
practice the curves found by the automatic method are acceptably
near to those obtained by the manual method.
The effect of substrate consumption can be accounted for
mathematically and exact determination of enzyme activity is
readily possible when higher precision is required or if other
substrates would be employed (see annexe). Yet it is important
that the substrate concentration should not diminish too much
during the experiment because it is preferable that any inhibitory
effects of the chromogenic substrate remain constant during the
exper imen[  (see be low) .
The technique thus faithfully renders the time course of the
amidolytic enzyme concentration. The next question is in how far
the presence of SQ68, influences this course.
Influence of SQ68 on the Amidolytic Activity Curve,
Selection of a Suitable Substrate Concentration
Part of the amidolytic activity must be attributed to factor Xa
because of the relatively high turnover-number of SQ 68 with that
enzyme (Table 1). This is counteracted by the high K-, which also
assures little inhibition of physiological factor Xa activity by the
substrate. Indeed no important inhibition of prothrombinase
activity is found (Fig. 6). The peak activity of factor Xa in clotting
plasma is around 10 nM (7). With the kinetic constants of Thble 1
one can calculate that this amount of factor Xa will cause a oNA
production that, at a SQ68 concentration of 500 uM, is lesJthat
10Y" of that of the peak activity of thrombin.
AT Ill is a pseudosubshate that attacks the active centre of
thrombin. A chromogenic substrate will compete with AT III for
this active centre and therefore compctitively inhibits AT III
action (8). Frorn standard enzymology it follows that, because the
ATIII  (-2.5 pM) and the SQ68 (>100 pM) are in excess over
the thrombin (<200 nM), the pseudo first order constant of
AI III dependent thrombin decay (fr1) in good approximation
decreases by a factor K-l(K- + S) (S : substrate conccntration,
K- : Michaelis constant). This explains why increasing concen-
trations of SQ 68 cause increasing amounts of thrombin to be
generated (Figs.3 and 4)
Because the concentration of SQ 68 hardly diminishes during
the experiment, its effect on the decay of thrombin is essentially
constant. The effect of an additional inhibitor, like heparin,
remains unaltered when expressed as a percentage of an uninhib-
i ted control (Fig.7).
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allows to dissect the OD development due to the action of the free
thrombin (Fig.9C) from the OD generated by o2 M-thrombin
(Fig.9B, see further annexe). The steady end-level of the
thrombin-trace represents the thrombin potential.
The k2 term implicitly incorporates the o2 macroglobulin
concentration, in fact the plasma to plasma variations of t2 must
be attributed to variations in o2 macroglobulin concentration. The
algorithm of the annexe seeks ft2 (multiplied by the constant f) for
each individual experiment and therefore eliminates this variation
as a source of error. When SQ68 is used as a substrate then
f  : 0 . 7 6 3 .
If k2 and / have been determined before, then the colour
development due to free thrombin can be calculated in real time.
From this the concentration of free thrombin can be calculated.
again in real time, because the reaction velocity (first derivative of
the OD trace) is dependent on the thrombin concentration and a
number of known constants: initial substrate concentration (56),
turnover number (k"u,) and Michaelis constant (K-) (see annexe).
With an unknown plasma sample, k2 . f can be obtained from
the experimental curve after the experiment is finished and the
concentration curve of free thrombin can then still be calculated
(see annexe). Also k2 . f can be guessed in order to obtain an
approximately correct thrombin generation curve on line, that can
be corrected after the experiment is finished. We reported before
that k2 equals 0.232 + 0.004 min I (SEM; n : 25) (3), in the
presence of 500 pM SQ68 this reduces to 0.136 min-1. This value
is a safe guess unless patients are studied in which an increase of
a2 macroglobulin is to be expected.
The steady end,level of the curve that represents the amount of
substrate split by free thrombin (ETP in Fig. 9), is proportional ro
the thrombin potential. Knowing the kinetic constants of Se6g
we can calculate how much thrombin has been acting on the
substrate and for how long. The dimension of this figure is
thrombin concentration x time (i. e. nM min). The normal value
of the thrombin potential is 487 + 2l nM min (n : 12) (12).
The TP directly indicates how much of any physiological
substrate present in, or in contact with, the plasma can be
converted by thrombin if the plasma is triggered. The Tp is
identical to the time-concentration integral of the formed throm-
bin, i. e. the surface under the thrombin generation curve. The
surface under the thrombin generation curve has been introduced
very early in tests for prothrombin estimation (11, 13). It indeed
can be traced back into the 19th century (1a). In the more recent
literature it is not frequently encountered, a. o. because it
requires time consuming experimentation.
Use of the Thrombin Potential (TP)
The overall activity of the clotting system is usually assessed by
measuring a coagulation time. This type of test comes r'n many
varieties, but it always essentially measures the time that elapses
until a level of 10-20 nM of thrombin is formed in the reaction
mixture (15). Spectrophotometric tests that are meant to replace
clotting tests also measure the moment of onset of exolosive
thrombin generation. At that moment, the peak of thiombin
formation (100-300 nM) is still to come. Often, e. g. in plasma
that clots via the extrinsic pathway in the presence of heparin, the
lag-phase of thrombin formation is hardly prolonged even when
the peak amount is significantly inhibired (2, 3). In general it can
be said that alterations of the clotting system are not always
necessarily reflected in the lag-time of thrombin formation, i e. in
the clotting time.
Recent research tends to stress the central position of thrombin
in the pathogenesis of thrombosis (16, 17, sei also 18 and 19 for
an overview). Thrombin appears as the pivotal enzyme in
haemostasis and thrombosis. Its effects are due to its action on a
number ofphysiological substrates (e. g. the tethered ligand ofthe
platelet membrane, fibrinogen). The magnitude of these effects is
determined by the amount of substrate that thrombin converts.
This amount is always proportional to the thrombin level com-
bined with the time that the thrombin can act, i. e. to the time
integral of the concentration of free thrombin, i. e. to the surface
under the TGC, i e. to the TP. It is easily seen that the amount of
the artificial substrate that is converted by thrombin is necessarily
proportional to the amount of any physiological substrate that can
be converted by this thrombin. It therefore is a direct indicator of
the haemostatic- and thrombotic action that this plasma can
potentially exert via thrombin.
It is our conjecture that the influence of an anticoagulant on
the thrombin potential is a direct indicator of its efficiency. It
therefore is important that inhibitions observed by the continuous
method correlate well with those seen in the direct method
(Fig 7). Preliminary experiments indicate that the continuous
method lends itself well to adaptation to a laboratory auromarlon.
It may be interest to those that cannot adopt the Se 68 method
that the o2 macroglobulin-thrombin level in serum is a direct
indicator of the thrombin potential, be it with individual varia-
tions in o2 macroglobulin level as a confounding factor (Fig 8). In
cases where one wants to investigate the influence on the
thrombin potential of inhibitors added to a plasma sample the o,2
macroglobulin level is equal in all samples and the o,2 macroglobu-
lin-thrombin level after coagulation directly indicates inhibition of
the thrombin potential relative to the control.
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Annex
Calculation of the Thronbin Potential from Integral Thrombin
Generation Curves
Kessels H. Willems GM, and Hemker HC
The method described in this article records a range of optical density
readings together with corresponding time values. Thcse discrcte optical
density-time pairs reflect both the integral of the thrombin concentration
and the integral of thc o2 M-thrombin complex concentration. Since the
formation of the n2 M-thrombin complex atlheres to simple first-order
kinetics, the integral of the thrombin concentration can easily bc obtained
as described below
Abbreviations used are:
frrtt o2 M-thrombin concentration at time /
M,: integral of o2 M-thrombin concentration at timc ,
€tt thrombin concentration at time /
E,: integral of thrombin concentration (thrombin potcntial) at time /
O,: optical dcnsity at time /
S,: conccntration of chromogenic substrate Se6g at time I
kz: second ordcr rate constant of n2 M-thrombin complex formation
k.ntrr turnovel number of SQ68 by thrombin
kcat2i turnover number of SQ 68 by the tr.2 M-thrombin complex
I: turnovcr number of SQ 68 due to o,2 M-thrombin rclative to the
tulnover number due to thrombin
K*: Michaclis constant for the conversion reaction of Se6g by
thrombin and by the o2 M-thrombin complex
At any moment the rate of formation of the o2 M-thrombin complex is
proportional to the conccntration of thrombin:
integration betwecn 0 and r gives:
I dmr|  - C T
J d t
Slflce z1; - 0 this is equal to:
m, :  k2 '  E,  (3)
At any moment, the convcrsion velocity of thc substratc is the sum
of thc convclsion velocities by thrombin and the tr2 M-thrombin complcx:
ds s, s,k "  
" r  
( ,
d1 s,  + K, ,  S,  + K,"
which resolves into:
E _
so -s ,+  K ( ln 56- ln S,)
- f - M ,
t
- b l e . d r
0
(2)
(5 )t.
with / equal ro k.,,p/k.,,11.
5', can bc obtained from:
S,:  So -  Ole
e being thc molar absorption coet1icient of
at a wavelcngth of 405 nm.
Since measurcment is carried out at discretc
bc derived from (3) as follows:
(6)
para nitro aniline
time points, M, can
(1  1 )
AM,
Ll
so that :
LM,:  l r ,  8, .  O,  (g)
and:
M,, :  M,, ,+ k2 Et .  ( t ,  -  t ,_)  (9)
Using cquations (5), (6) and (9) the time course of the inteeral of the
thrombin conccntration can be calculated from the time course of optical
density and ft2. An intcgral thrombin curve goes to a stcady cnd_level
which directly rcprescnts thc value of the thrombin potcntial.
Thc valuc of k2 is often not known in advance. It ian bc detcrmined in
separate expenments as reported earlier (ref.1). Alternatively, if it is
assumed that after a certain timepoint t" prothrombinase conversion has
stopped and the conccntration of free thrombin is 0, then k2 can be
estimated directly from the optical density vs time curve tn a manner
analogous to subsampled thrombin generation curves as described above.
A relatively simple way to do this is to calculate the time courses of the
thrombin potential for a range of assumed values r fot f . k2, and
determine the slope of these curves from time /" on using linear regression.
In casc the r value is bigger than thc true k2value, the thrombin potential
will decrease aftcr 1". If, on the other hand, the value is smaller than the
true value, the slope will be positive. The true k2 value is that value where
the slope of the thrombin potential curve after time t is zer.o. It can be
obtained by plotting the obtained slopes versus thcir conesponding r<
values and determining the intersect of the resulting curve with thc x-axis.
It proved practical to estimate this intersect by fitting the slope vs K curve
to thc following exponential:
s l ope :ae1 ' "+c  ( 10 )
so that k2 can be obtaincd from the parameters a, b, and c of
this exponential:
1n (-c)  -  ln (a)
I  K ) :
b
_  
_  ^ ) c r
d I
A computer program (for IBM PC compatiblcs) that both estimates k2
and calculates the time course of the integral thrombin curve as describccl
above, can bc obtaincd from the authors
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( i )
